Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459062) titled 'Spectral Cancer Tissue Recognition - I' on March 3.

Study Type: Observational

Primary Sponsor: SPCTR

Condition: Margin Assessment Breast Cancer

Recruitment Status: Recruiting

Date of First Enrollment: January 12, 2026

Target Sample Size: 100

Countries of Recruitment: Netherlands

To know more, visit https://clinicaltrials.gov/study/NCT07459062

Published by HT Digital Content Services with permission from Health Daily Digest....